Price $116.82 |
Market Cap
209.42B
|
Sector Health Care |
Div. Growth
19.10%
|
|
P/E
32.8
|
P/B
6.17
|
P/S
5.18
|
Dividend %
1.50%
|
|
P/CF
53.9
|
P/FCF
36.4
|
Op. Cash Flow
10.63M
|
FCF
3.2
|
|
Op. Margin
18.60%
|
Net Margin
15.80%
|
ROE
19.40%
|
ROI
9.70%
|
|
ROA
8.90%
|
EPS Growth
104.30%
|
Current Ratio
1.7
|
Debt/Equity
56.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| La Jolla Pharmaceutical Compan (LJPC) | $3.84 | - | - | 109.7M | Strong Buy |
| Emmaus Life Sciences Inc (EMMA) | $1.50 | - | - | 78.9M | Strong Buy |
| Lannett Company, Inc. (LCI) | $2.41 | - | - | 126.8M | Strong Buy |
| Psychemedics Corp. (PMD) | $8.23 | - | - | 46.6M | Strong Buy |
| Capital Senior Living Corporat (CSU) | $30.11 | - | - | 77.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
